EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Melanie Engler iD, Dan Albers iD, Pascal Von Maltitz, Rüdiger Groß, Jan Münch iD, Ion Cristian Cirstea iD

Life Science Alliance · 2023-09 · 6 (9) · e202201880

DOI: 10.26508/lsa.202201880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 04.07.2023. Verfasst von Melanie Engler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 triggered the most severe pandemic of recent times. To enter into a host cell, SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2). However, subsequent studies indicated that other cell membrane receptors may act as virus-binding partners. Among these receptors, the epidermal growth factor receptor (EGFR) was hypothesized not only as a spike protein binder, but also to be activated in response to SARS-CoV-2. In our study, we aim at dissecting EGFR activation and its major downstream signaling pathway, the mitogen-activated signaling pathway (MAPK), in SARS-CoV-2 infection. Here, we demonstrate the activation of EGFR–MAPK signaling axis by the SARS-CoV-2 spike protein and we identify a yet unknown cross talk between ACE2 and EGFR that regulated ACE2 abundance and EGFR activation and subcellular localization, respectively. By inhibiting the EGFR-MAPK activation, we observe a reduced infection with either spike-pseudotyped particles or authentic SARS-CoV-2, thus indicating that EGFR serves as a cofactor and the activation of EGFR-MAPK contributes to SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Angiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AErbB ReceptorsSpike Glycoprotein, Coronavirus

Substanzen

Angiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AErbB Receptorsspike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusEGFR protein, human

Autor:innen und Institutionen

  • Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
  • Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany ion.cirstea@uni-ulm.de.

ORCID-Profile: Melanie Engler, Dan Albers, Jan Münch, Ion Cristian Cirstea

Förderung

  • Bundesministerium für Bildung und Forschung
  • Deutsche Forschungsgemeinschaft
  • Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg

Zitieren

APA

Engler, M., Albers, D., Von Maltitz, P., Groß, R., Münch, J., & Cirstea, I. C. (2023). ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection. Life Science Alliance, 6(9), e202201880. https://doi.org/10.26508/lsa.202201880

Vancouver

Engler M, Albers D, Von Maltitz P, Groß R, Münch J, Cirstea IC. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection. Life Science Alliance. 2023;6(9):e202201880. doi:10.26508/lsa.202201880

BibTeX
@article{Engler2023,
  author = {Engler, Melanie and Albers, Dan and Von Maltitz, Pascal and Groß, Rüdiger and Münch, Jan and Cirstea, Ion Cristian},
  title = {ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection},
  journal = {Life Science Alliance},
  year = {2023},
  volume = {6},
  number = {9},
  pages = {e202201880},
  doi = {10.26508/lsa.202201880}
}
Kostenlos starten →